Fig. 4From: Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancerFunctional enrichment analysis of DEGs from identified from SUM-159 cells. Metabolic pathways enriched with (A) upregulated (B) downregulated genes from JQ1 treatment. Metabolic pathways enriched with (C) upregulated genes from GSK2801 treatment. (D) upregulated and (E) downregulated genes from JQ1 + GSK2801 combined treatmentBack to article page